Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,509 | 214 | 99.2% |
| Education | $27.16 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dexcom, Inc. | $551.51 | 14 | $0 (2024) |
| Mannkind Corporation | $493.48 | 34 | $0 (2022) |
| Novo Nordisk Inc | $405.70 | 28 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $350.58 | 28 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $275.24 | 18 | $0 (2022) |
| ABBVIE INC. | $196.45 | 13 | $0 (2023) |
| Amarin Pharma Inc. | $181.06 | 11 | $0 (2021) |
| Abbott Laboratories | $176.28 | 11 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $146.24 | 12 | $0 (2022) |
| Lilly USA, LLC | $102.32 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78.15 | 2 | Dexcom, Inc. ($78.15) |
| 2023 | $434.10 | 19 | Dexcom, Inc. ($169.76) |
| 2022 | $1,375 | 82 | Dexcom, Inc. ($303.60) |
| 2021 | $1,649 | 113 | MannKind Corporation ($335.28) |
All Payment Transactions
216 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $37.62 | General |
| Category: Endocrinology | ||||||
| 04/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $40.53 | General |
| Category: Endocrinology | ||||||
| 11/27/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $48.64 | General |
| Category: Endocrinology | ||||||
| 10/13/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: Endocrinology | ||||||
| 07/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 07/03/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $45.57 | General |
| Category: Endocrinology | ||||||
| 07/01/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.08 | General |
| Category: Insulin Pump | ||||||
| 06/28/2023 | Tolmar, Inc. | JATENZO (Drug) | Education | In-kind items and services | $15.45 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 06/09/2023 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Diabetes | ||||||
| 04/25/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes | ||||||
| 04/06/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.93 | General |
| Category: Insulin Pump | ||||||
| 03/24/2023 | Amryt Pharma Holdings Ltd | MYCAPSSA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Endocrinology | ||||||
| 03/20/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiology | ||||||
| 03/13/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $42.70 | General |
| Category: Endocrinology | ||||||
| 02/24/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: DIABETES | ||||||
| 02/17/2023 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: IMMUNOLOGY | ||||||
| 02/03/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Diabetes | ||||||
| 01/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: DIABETES | ||||||
| 01/24/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 01/11/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.57 | General |
| Category: Insulin Pump | ||||||
| 12/16/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $43.93 | General |
| Category: Endocrinology | ||||||
| 12/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Diabetes | ||||||
| 11/24/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes Care | ||||||
| 11/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 224 | 302 | $30,229 | $9,241 |
| 2022 | 5 | 400 | 678 | $60,344 | $19,581 |
| 2021 | 5 | 419 | 706 | $68,071 | $24,600 |
| 2020 | 10 | 604 | 766 | $66,586 | $15,211 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 81 | $19,683 | $5,970 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 28 | $4,816 | $1,300 | 27.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 25 | 35 | $2,380 | $789.38 | 33.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 53 | 77 | $2,387 | $733.04 | 30.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 30 | $300.00 | $252.00 | 84.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 38 | 51 | $663.00 | $196.35 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 130 | $27,449 | $9,013 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 139 | $20,443 | $6,778 | 33.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 103 | 192 | $5,952 | $1,786 | 30.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 33 | 70 | $4,809 | $1,452 | 30.2% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 87 | 147 | $1,691 | $551.65 | 32.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 175 | $35,350 | $13,011 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 143 | $19,591 | $7,422 | 37.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 108 | 214 | $6,634 | $2,059 | 31.0% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 38 | 79 | $5,451 | $1,743 | 32.0% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 68 | 95 | $1,045 | $365.49 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 169 | 254 | $34,798 | $8,351 | 24.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 53 | 62 | $12,171 | $3,043 | 25.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 125 | 165 | $6,845 | $1,508 | 22.0% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 22 | 36 | $2,946 | $713.16 | 24.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 28 | 30 | $2,386 | $449.70 | 18.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 106 | 116 | $1,740 | $341.94 | 19.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 27 | 28 | $2,100 | $291.06 | 13.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 14 | 14 | $840.00 | $184.49 | 22.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2020 | 30 | 31 | $1,860 | $176.18 | 9.5% |
About Jacqueline Baker, PA-C
Jacqueline Baker, PA-C is a Physician Assistant healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285705558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacqueline Baker, PA-C has received a total of $3,536 in payments from pharmaceutical and medical device companies, with $78.15 received in 2024. These payments were reported across 216 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,509).
As a Medicare-enrolled provider, Baker has provided services to 1,647 Medicare beneficiaries, totaling 2,452 services with total Medicare billing of $68,633. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Lexington, KY
- Active Since 11/10/2006
- Last Updated 12/09/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1285705558
Products in Payments
- Dexcom G6 Transmitter (Medical Supply) $551.51
- AFREZZA (Drug) $493.48
- JARDIANCE (Drug) $353.67
- FARXIGA (Drug) $236.29
- Vascepa (Drug) $181.06
- SYNTHROID (Drug) $180.77
- Wegovy (Drug) $133.09
- Ozempic (Drug) $103.77
- SOLIQUA 100/33 (Biological) $88.39
- Omnipod (Device) $87.36
- Rybelsus (Drug) $83.56
- FREESTYLE LIBRE 2 (Device) $82.02
- NEXLETOL (Drug) $64.95
- Kerendia (Drug) $64.69
- BD Nano 2nd Gen Pen Needle (Device) $62.92
- V-GO DISPOSABLE INSULIN DELIVERY (Device) $58.85
- NOCDURNA (Drug) $50.87
- Korlym (Drug) $45.43
- TOUJEO (Biological) $44.52
- Saxenda (Drug) $44.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lexington
Ms. Lauren Meade, Pa-C, PA-C
Physician Assistant — Payments: $586,865
Brandice Harrison, Pa-C, PA-C
Physician Assistant — Payments: $581,472
Amber Erwin, Pa-C, PA-C
Physician Assistant — Payments: $11,278
Mr. Edwin Robbins, Pa-C, PA-C
Physician Assistant — Payments: $9,751
Vedrana Knezevic, Pa-C, PA-C
Physician Assistant — Payments: $9,611
Sarah Dougherty, Pa-C, PA-C
Physician Assistant — Payments: $7,472